IP Library Assignment 075952/0812
Patent Assignment
Reel/Frame 075952/0812

Patent Security Agreement

Recorded: 2026-07-13 Pages: 10
Assignors
ESPERION THERAPEUTICS, INC.
Executed: 2026-07-13
RESQ PHARMACEUTICALS LLC
Executed: 2026-07-13
Assignee
BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
C/O MUFG CORPORATE GOVERNANCE LIMITED, 51 LIME STREET, 19TH FLOOR, LONDON, EC3M 7DQ, UNITED KINGDOM
Covered Properties (26)
Compositions Containing and Therapies Using Bempedoic Acid and Tolvaptan
Application: 18/565,762 →
Publication: US US20240366625A1
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 15/558,084 →
Publication: US US20180064671A1
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 17/136,870 →
Publication: US US20210361605A1
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 18/601,088 →
Publication: US US20240398746A1
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing Cardiovascular Disease
Application: 15/558,519 →
Publication: US US20180078518A1
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 18/949,376 →
Publication: US US20250064767A1
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Patent: 7,335,799 →
Application: 10/743,470 →
Publication: US US20050043278A1
Macrocyclic Inhibitors of Atp Citrate Lyase
Application: 18/862,295 →
Publication: US US20250289793A1
Methods for Reducing the Risk of Diabetes in Patients Being Treated for High Cholesterol-Related Illnesses
Application: 17/271,045 →
Publication: US US20210322376A1
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/150,325 →
Publication: US US20210139401A1
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/577,829 →
Publication: US US20220388937A1
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/742,728 →
Publication: US US20220281795A1
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/867,744 →
Publication: US US20230183160A1
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 18/297,846 →
Publication: US US20230250043A1
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 18/450,591 →
Publication: US US20240182396A1
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 18/632,996 →
Publication: US US20240286987A1
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 18/657,105 →
Publication: US US20240317665A1
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 19/280,575 →
Publication: US US20260146017A1
Salt Forms of Bempedoic Acid and Methods for Using the Same
Application: 17/620,885 →
Publication: US US20230141635A1
Methods and Compositions for Treating Edema Refractory to Oral Diuretics
Application: 17/112,899 →
Publication: US US20210169833A1
Methods and Compositions for Treating Edema Refractory to Oral Diuretics
Application: 17/345,550 →
Methods and Compositions for Treating Edema Refractory to Oral Diuretics
Application: 17/680,591 →
Publication: US US20220287996A1
Methods and Compositions for Treating Edema Refractory to Oral Diuretics
Application: 18/916,471 →
Publication: US US20250032436A1
Methods and Compositions for Treating Edema Refractory to Oral Diuretics
Application: 19/208,335 →
Publication: US US20250268853A1
Subcutaneous Formulation and Methods for Treating Edema Refractory to Oral Diuretics
Application: 18/568,440 →
Publication: US US20240285566A1
Compositions Containing, and Combination Therapies Using Bempedoic Acid and a Glp-1 Receptor Agonist
Application: 19/499,792 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 1, 2004
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 015945/0158 →
Merger Oct 14, 2014
From: ESPERION THERAPEUTICS, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033946/0330 →
Security Interest Jun 28, 2019
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 049623/0629 →
Assignment of Assignor's Interest Oct 25, 2019
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050823/0885 →
Security Interest Apr 26, 2021
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 056044/0988 →
Assignment of Assignor's Interest Sep 17, 2021
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 057515/0836 →
Assignment of Assignor's Interest Jun 13, 2022
From: PATHEON AUSTRIA GMBH & CO KG
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0170 →
Assignment of Assignor's Interest Jun 13, 2022
From: SELIG, PHILIPP
To: PATHEON AUSTRIA GMBH & CO KG.
Reel/Frame 060183/0121 →
Assignment of Assignor's Interest Jun 13, 2022
From: COOPER, ARTHUR JOHN; GOPAL, DAMODARAGOUNDER
To: OLON RICERCA BIOSCIENCE LLC
Reel/Frame 060183/0147 →
Assignment of Assignor's Interest Jun 13, 2022
From: COPP, RICHARD; CIMARUSTI, CHRISTOPHER M.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0094 →
Assignment of Assignor's Interest Jun 13, 2022
From: OLON RICERCA BIOSCIENCE LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0159 →
Assignment of Assignor's Interest Jun 13, 2022
From: LANE, JONATHAN; BARKMAN, MICHAEL; AMIN, RASIDUL; FRANK, MICHELLE
To: CORDEN PHARMA COLORADO, INC.
Reel/Frame 060183/0076 →
Assignment of Assignor's Interest Jun 13, 2022
From: CORDEN PHARMA COLORADO, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0088 →
Assignment of Assignor's Interest Jun 30, 2023
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 064129/0705 →
Assignment of Assignor's Interest Jan 8, 2024
From: SELIG, PHILIPP
To: PATHEON AUSTRIA GMBH & CO KG
Reel/Frame 066048/0529 →
Assignment of Assignor's Interest Jan 8, 2024
From: PATHEON AUSTRIA GMBH & CO KG
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0540 →
Assignment of Assignor's Interest Jan 8, 2024
From: COOPER, ARTHUR JOHN; GOPAL, DAMODARAGOUNDER
To: OLON RICERCA BIOSCIENCE LLC
Reel/Frame 066048/0576 →
Assignment of Assignor's Interest Jan 8, 2024
From: OLON RICERCA BIOSCIENCE LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0583 →
Assignment of Assignor's Interest Jan 8, 2024
From: ABDELNASSER, MOHAMED
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0362 →
Assignment of Assignor's Interest Jan 8, 2024
From: CORDEN PHARMA COLORADO, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0570 →
Assignment of Assignor's Interest Jan 8, 2024
From: COPP, RICHARD; CIMARUSTI, CHRISTOPHER M.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0513 →
Assignment of Assignor's Interest Jan 8, 2024
From: LANE, JONATHAN; BARKMAN, MICHAEL; AMIN, RASIDUL; FRANK, MICHELLE
To: CORDEN PHARMA COLORADO, INC.
Reel/Frame 066048/0561 →
Release of Security Interest Jun 27, 2024
From: EIGER III SA LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 067963/0094 →
Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement Jul 19, 2024
From: ABDELNASSER, MOHAMED
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 068459/0136 →
Security Interest Dec 13, 2024
From: ESPERION THERAPEUTICS, INC.
To: GLAS AMERICAS LLC
Reel/Frame 069582/0756 →